Inhibition of β-lactamase function by de novo designed peptide.
Inhibition of β-lactamase function by de novo designed peptide.
复制标题
DOI:
10.1371/journal.pone.0290845
复制
发表时间:
2023
期刊:
影响因子:
3.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Antimicrobial resistance is a great public health concern that is now described as a “silent pandemic”. The global burden of antimicrobial resistance requires new antibacterial treatments, especially for the most challenging multidrug-resistant bacteria. There are various mechanisms by which bacteria develop antimicrobial resistance including expression of β-lactamase enzymes, overexpression of efflux pumps, reduced cell permeability through downregulation of porins required for β-lactam entry, or modifications in penicillin-binding proteins. Inactivation of the β-lactam antibiotics by β-lactamase enzymes is the most common mechanism of bacterial resistance to these agents. Although several effective small-molecule inhibitors of β-lactamases such as clavulanic acid and avibactam are clinically available, they act only on selected class A, C, and some class D enzymes. Currently, none of the clinically approved inhibitors can effectively inhibit Class B metallo-β-lactamases. Additionally, there is increased resistance to these inhibitors reported in several bacteria. The objective of this study is to use the Resonant Recognition Model (RRM), as a novel strategy to inhibit/modulate specific antimicrobial resistance targets. The RRM is a bio-physical approach that analyzes the distribution of energies of free electrons and posits that there is a significant correlation between the spectra of this energy distribution and related protein biological activity. In this study, we have used the RRM concept to evaluate the structure-function properties of a group of 22 β-lactamase proteins and designed 30-mer peptides with the desired RRM spectral periodicities (frequencies) to function as β-lactamase inhibitors. In contrast to the controls, our results indicate 100% inhibition of the class A β-lactamases from Escherichia coli and Enterobacter cloacae. Taken together, the RRM model can likely be utilized as a promising approach to design β-lactamase inhibitors for any specific class. This may open a new direction to combat antimicrobial resistance.
登录
查看更多内容
影响因子:
5.2
作者:
Lin J;Nishino K;Roberts MC;Tolmasky M;Aminov RI;Zhang L
通讯作者:
Zhang L
影响因子:
11.5
作者:
Bebrone, Carine;Lassaux, Patricia;Galleni, Moreno
通讯作者:
Galleni, Moreno
影响因子:
4.2
作者:
Almansour, Nahlah M.;Pirogova, Elena;Istivan, Taghrid S.
通讯作者:
Istivan, Taghrid S.
影响因子:
4.9
作者:
Boyd, Sara E.;Livermore, David M.;Hope, William W.
通讯作者:
Hope, William W.
影响因子:
5.2
作者:
通讯作者:
--